Until recently, a heart disease called ATTR amyloidosis had limited treatment options. Since 2021, four drug trials led by Prof Marianna Fontana and Prof Julian Gillmore UCL Faculty of Medical Sciences have shown promise in transforming treatment for this devastating condition ucl.ac.uk/news/2024/sep/…